These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26179604)
1. β3-Adrenoceptor, glutathionylation, and diabetic cardiomyopathy. Focus on "β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade". Black SM Am J Physiol Cell Physiol; 2015 Sep; 309(5):C283-5. PubMed ID: 26179604 [No Abstract] [Full Text] [Related]
2. β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade. Karimi Galougahi K; Liu CC; Garcia A; Fry NA; Hamilton EJ; Figtree GA; Rasmussen HH Am J Physiol Cell Physiol; 2015 Sep; 309(5):C286-95. PubMed ID: 26063704 [TBL] [Abstract][Full Text] [Related]
3. β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia. Karimi Galougahi K; Liu CC; Garcia A; Gentile C; Fry NA; Hamilton EJ; Hawkins CL; Figtree GA J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896479 [TBL] [Abstract][Full Text] [Related]
4. β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification. Bundgaard H; Liu CC; Garcia A; Hamilton EJ; Huang Y; Chia KK; Hunyor SN; Figtree GA; Rasmussen HH Circulation; 2010 Dec; 122(25):2699-708. PubMed ID: 21135361 [TBL] [Abstract][Full Text] [Related]
5. Beta3-adrenoceptor agonist stimulation of the Na+, K+ -pump in rat skeletal muscle is mediated by beta2- rather than beta3-adrenoceptors. Murphy KT; Bundgaard H; Clausen T Br J Pharmacol; 2006 Nov; 149(6):635-46. PubMed ID: 17016512 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of the cardiac myocyte Na+-K+ pump due to reversal of its constitutive oxidative inhibition. Chia KK; Liu CC; Hamilton EJ; Garcia A; Fry NA; Hannam W; Figtree GA; Rasmussen HH Am J Physiol Cell Physiol; 2015 Aug; 309(4):C239-50. PubMed ID: 26084308 [TBL] [Abstract][Full Text] [Related]
7. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell. Khan S; Ahmad SS; Kamal MA Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress. Han DN; Zhang DH; Wang LP; Zhang YS Peptides; 2013 Jun; 44():120-6. PubMed ID: 23562714 [TBL] [Abstract][Full Text] [Related]
9. Role of the β Kayki Mutlu G; Arioglu Inan E; Karaomerlioglu I; Altan VM; Yersal N; Korkusuz P; Rocchetti M; Zaza A Mol Cell Biochem; 2018 Sep; 446(1-2):149-160. PubMed ID: 29363058 [TBL] [Abstract][Full Text] [Related]
10. Glutathionylation-Dependence of Na(+)-K(+)-Pump Currents Can Mimic Reduced Subsarcolemmal Na(+) Diffusion. Garcia A; Liu CC; Cornelius F; Clarke RJ; Rasmussen HH Biophys J; 2016 Mar; 110(5):1099-109. PubMed ID: 26958887 [TBL] [Abstract][Full Text] [Related]
11. Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation. Figtree GA; Liu CC; Bibert S; Hamilton EJ; Garcia A; White CN; Chia KK; Cornelius F; Geering K; Rasmussen HH Circ Res; 2009 Jul; 105(2):185-93. PubMed ID: 19542013 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy. Carillion A; Feldman S; Na N; Biais M; Carpentier W; Birenbaum A; Cagnard N; Loyer X; Bonnefont-Rousselot D; Hatem S; Riou B; Amour J PLoS One; 2017; 12(7):e0180103. PubMed ID: 28727746 [TBL] [Abstract][Full Text] [Related]
13. Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats. Marwaha A; Lokhandwala MF Am J Physiol Renal Physiol; 2006 Jul; 291(1):F58-66. PubMed ID: 16478977 [TBL] [Abstract][Full Text] [Related]
14. Oxidative regulation of the Na(+)-K(+) pump in the cardiovascular system. Figtree GA; Keyvan Karimi G; Liu CC; Rasmussen HH Free Radic Biol Med; 2012 Dec; 53(12):2263-8. PubMed ID: 23085513 [TBL] [Abstract][Full Text] [Related]
15. β3-Adrenoceptor-mediated responses in diabetic rat heart. Kayki-Mutlu G; Arioglu-Inan E; Ozakca I; Ozcelikay AT; Altan VM Gen Physiol Biophys; 2014; 33(1):99-109. PubMed ID: 24334532 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone. Aragno M; Parola S; Brignardello E; Manti R; Betteto S; Tamagno E; Danni O; Boccuzzi G Free Radic Biol Med; 2001 Oct; 31(8):935-42. PubMed ID: 11595378 [TBL] [Abstract][Full Text] [Related]
17. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064 [TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway. Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361 [TBL] [Abstract][Full Text] [Related]
19. Effects of β(3)-adrenoceptor activation on expression of pancreatic adrenoceptors and angiotensin II receptors in ApoE(-/-) mice. Song JY; Li YF; Zhi-Li J; Guo YQ Eur J Pharmacol; 2015 Oct; 764():134-139. PubMed ID: 26102566 [TBL] [Abstract][Full Text] [Related]
20. A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy. Turan B Curr Drug Deliv; 2016; 13(3):418-23. PubMed ID: 26593438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]